Billing Beat

Breast and Ovarian Cancer Gene Sequence Analysis

May 3, 2010

Effective for dates of service on or after May 1, 2010, HCPCS code S3820 (complete BRCA1 and BRCA2 gene sequence analysis for susceptibility to breast and ovarian cancer) is a once-in-a-lifetime procedure and requires a Treatment Authorization Request (TAR). A TAR for HCPCS code S3820 requires documentation of one or more of the following numbered criteria….

Sign up for Billing Beat